Redhill Biopharma
RDHL0.48030.76% ( -0.0037 )
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Redhill Biopharma(RDHL) the EBIT is -1.738 M (-2.45%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B2.45%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf